DRTECH Corporation Stock

Equities

A214680

KR7214680001

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. 06:00:00 2024-05-30 pm EDT 5-day change 1st Jan Change
3,825 KRW -7.38% Intraday chart for DRTECH Corporation -11.87% -10.21%
Sales 2022 89.48B 64.61M Sales 2023 92.44B 66.74M Capitalization 309B 223M
Net income 2022 5.97B 4.31M Net income 2023 -2.25B -1.62M EV / Sales 2022 1.09 x
Net Debt 2022 17.14B 12.37M Net Debt 2023 33.32B 24.06M EV / Sales 2023 3.7 x
P/E ratio 2022
14.5 x
P/E ratio 2023
-125 x
Employees 313
Yield 2022 *
-
Yield 2023
-
Free-Float 68.24%
More Fundamentals * Assessed data
Dynamic Chart
DRTECH Corporation(KOSDAQ:A214680) added to S&P Global BMI Index CI
DRTECH Corporation announced that it has received KRW 20 billion in funding CI
DRTECH Corporation announced that it expects to receive KRW 20 billion in funding CI
DRTECH Corporation announced that it has received KRW 8.525 billion in funding from Osstem Implant Co., Ltd. CI
DRTECH Corporation announced that it expects to receive KRW 8.525 billion in funding from Osstem Implant Co., Ltd. CI
DRTECH Corporation announced that it has received KRW 20 billion in funding from a group of investors CI
DRTECH Corporation announced that it expects to receive KRW 20 billion in funding from a group of investors CI
DRTECH Corporation announced that it has received KRW 12 billion in funding from Soosung Co.,Ltd., Industrial Bank of Korea, Investment Arm, Shinhan Eng & Const. Co.,Ltd, Meritz Securities Co., Ltd., Investment Arm, Hanbit Investment Corporation and other investors CI
DRTECH Corporation announced that it expects to receive KRW 12 billion in funding from Soosung Co.,Ltd., Industrial Bank of Korea, Investment Arm, Shinhan Eng & Const. Co.,Ltd, Meritz Securities Co., Ltd., Investment Arm, Hanbit Investment Corporation and other investors CI
DRTECH Corporation announced that it has received KRW 10 billion in funding from a group of investors CI
DRTECH Corporation announced that it expects to receive KRW 10 billion in funding from a group of investors CI
Hologic, Inc. sold 3% stake in DRTECH Corporation. CI
JW Holdings Corporation acquired 7.7% stake in DRTECH Corporation. CI
Hologic, Inc. acquired 5.8% stake in DRTECH Corporation. CI
DRTECH Corporation completed the acquisition of Hanwha Ace Special Purpose Acquisition 1st Co., Ltd. in a reverse merger transaction. CI
More news
1 day-7.38%
1 week-11.87%
1 month+11.35%
3 months+1.59%
6 months-14.91%
Current year-10.21%
More quotes
1 week
3 805.00
Extreme 3805
4 540.00
1 month
3 555.00
Extreme 3555
4 885.00
Current year
2 925.00
Extreme 2925
5 090.00
1 year
2 500.00
Extreme 2500
7 590.00
3 years
1 340.00
Extreme 1340
7 590.00
5 years
926.00
Extreme 926
7 590.00
10 years
926.00
Extreme 926
7 590.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 13-06-30
Chief Tech/Sci/R&D Officer 59 02-07-31
Director/Board Member 67 15-08-31
Members of the board TitleAgeSince
Director/Board Member 56 00-03-31
Director/Board Member 67 15-08-31
Chief Executive Officer 61 13-06-30
More insiders
Date Price Change Volume
24-05-31 3,825 -7.38% 6,419,319
24-05-30 4,130 -2.94% 1,698,913
24-05-29 4,255 -2.63% 3,905,787
24-05-28 4,370 -1.35% 3,178,092
24-05-27 4,430 +2.07% 6,935,345

End-of-day quote Korea S.E., May 30, 2024

More quotes
DRTECH Corporation, formerly Hanwha Ace Special Purpose Acquisition 1st Co., Ltd. is a Korea-based company principally engaged in manufacture of medical machines. The Company’s products include X-ray detector and related products. The Company also engaged in development of X-ray detector, image processing engine, medical software and medical portable solution.
More about the company
  1. Stock Market
  2. Equities
  3. A214680 Stock